Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis

Abstract Background The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. Methods From June 2000 to October 2009, 40 patients with cT2-3N0M0 rect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgery 2013-10, Vol.206 (4), p.482-487
Hauptverfasser: Yu, Chang Sik, M.D, Yun, Hae Ran, M.D, Shin, Eung Jin, M.D, Lee, Kang Yong, M.D, Kim, Nam Kyu, M.D, Lim, Seok-Byung, M.D, Oh, Seong Taek, M.D, Kang, Sung-Bum, M.D, Choi, Won Joon, M.D, Lee, Woo Yong, M.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 487
container_issue 4
container_start_page 482
container_title The American journal of surgery
container_volume 206
creator Yu, Chang Sik, M.D
Yun, Hae Ran, M.D
Shin, Eung Jin, M.D
Lee, Kang Yong, M.D
Kim, Nam Kyu, M.D
Lim, Seok-Byung, M.D
Oh, Seong Taek, M.D
Kang, Sung-Bum, M.D
Choi, Won Joon, M.D
Lee, Woo Yong, M.D
description Abstract Background The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. Methods From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis. Results Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor ( P = .040). Conclusions Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancer patients appears to be a safe and effective treatment, especially in pCR patients.
doi_str_mv 10.1016/j.amjsurg.2013.01.042
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443392574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002961013002948</els_id><sourcerecordid>1443392574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-ef79835f89c83e09e7f8446a6cb159e5fc033c281bdea8b401f9472641fdc02a3</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhi0EokvhJ4Aiceklqcd2EpsDVVXxUWklDsDZ8jpj6pCPxU4q9t9jswtIvXCyZ_TMa8-8Q8hLoBVQaC77yox9XMO3ilHgFYWKCvaIbEC2qgQp-WOyoZSyUjVAz8izGPsUAgj-lJwxLoViLduQsJ2tGQr8aX3081QYt2AoJpxN16_3ZloKe4fjHEznzZKB5Q6D2R8Kn9guARa7IqBdkojNUXhTmGL6zabUuA6LtzhlUZMSh-jjc_LEmSHii9N5Tr6-f_fl5mO5_fTh9uZ6W1oh5FKia5XktZPKSo5UYeukEI1p7A5qhbWzlHPLJOw6NHInKDglWtYIcJ2lzPBzcnHU3Yf5x4px0aOPFofBpPbWqEEIzhWrW5HQ1w_Qfl5D-m-meMvrpq5louojZcMcY0Cn98GPJhw0UJ1N0b0-maKzKZqCTqakulcn9XU3Yve36o8LCbg6ApjGce8x6Gg95tH6PFrdzf6_T7x9oGAHP_lk7Xc8YPzXjY5MU_05b0ZeDOD5IiT_BTp-tns</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1437356558</pqid></control><display><type>article</type><title>Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Yu, Chang Sik, M.D ; Yun, Hae Ran, M.D ; Shin, Eung Jin, M.D ; Lee, Kang Yong, M.D ; Kim, Nam Kyu, M.D ; Lim, Seok-Byung, M.D ; Oh, Seong Taek, M.D ; Kang, Sung-Bum, M.D ; Choi, Won Joon, M.D ; Lee, Woo Yong, M.D</creator><creatorcontrib>Yu, Chang Sik, M.D ; Yun, Hae Ran, M.D ; Shin, Eung Jin, M.D ; Lee, Kang Yong, M.D ; Kim, Nam Kyu, M.D ; Lim, Seok-Byung, M.D ; Oh, Seong Taek, M.D ; Kang, Sung-Bum, M.D ; Choi, Won Joon, M.D ; Lee, Woo Yong, M.D ; Colorectal Cancer Study Group, Korean Society of Coloproctology</creatorcontrib><description>Abstract Background The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. Methods From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis. Results Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor ( P = .040). Conclusions Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancer patients appears to be a safe and effective treatment, especially in pCR patients.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2013.01.042</identifier><identifier>PMID: 23849272</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Chemoradiotherapy ; Chemotherapy ; Colorectal cancer ; Female ; Humans ; Local excision ; Male ; Medical imaging ; Middle Aged ; Mortality ; Neoadjuvant chemoradiation therapy ; Neoadjuvant Therapy ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; NMR ; Nuclear magnetic resonance ; Rectal cancer ; Rectal Neoplasms - mortality ; Rectal Neoplasms - pathology ; Rectal Neoplasms - therapy ; Rectum - surgery ; Retrospective Studies ; Surgery</subject><ispartof>The American journal of surgery, 2013-10, Vol.206 (4), p.482-487</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Oct 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-ef79835f89c83e09e7f8446a6cb159e5fc033c281bdea8b401f9472641fdc02a3</citedby><cites>FETCH-LOGICAL-c448t-ef79835f89c83e09e7f8446a6cb159e5fc033c281bdea8b401f9472641fdc02a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1437356558?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23849272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Chang Sik, M.D</creatorcontrib><creatorcontrib>Yun, Hae Ran, M.D</creatorcontrib><creatorcontrib>Shin, Eung Jin, M.D</creatorcontrib><creatorcontrib>Lee, Kang Yong, M.D</creatorcontrib><creatorcontrib>Kim, Nam Kyu, M.D</creatorcontrib><creatorcontrib>Lim, Seok-Byung, M.D</creatorcontrib><creatorcontrib>Oh, Seong Taek, M.D</creatorcontrib><creatorcontrib>Kang, Sung-Bum, M.D</creatorcontrib><creatorcontrib>Choi, Won Joon, M.D</creatorcontrib><creatorcontrib>Lee, Woo Yong, M.D</creatorcontrib><creatorcontrib>Colorectal Cancer Study Group, Korean Society of Coloproctology</creatorcontrib><title>Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>Abstract Background The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. Methods From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis. Results Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor ( P = .040). Conclusions Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancer patients appears to be a safe and effective treatment, especially in pCR patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Chemoradiotherapy</subject><subject>Chemotherapy</subject><subject>Colorectal cancer</subject><subject>Female</subject><subject>Humans</subject><subject>Local excision</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Neoadjuvant chemoradiation therapy</subject><subject>Neoadjuvant Therapy</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Rectal cancer</subject><subject>Rectal Neoplasms - mortality</subject><subject>Rectal Neoplasms - pathology</subject><subject>Rectal Neoplasms - therapy</subject><subject>Rectum - surgery</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk1v1DAQhi0EokvhJ4Aiceklqcd2EpsDVVXxUWklDsDZ8jpj6pCPxU4q9t9jswtIvXCyZ_TMa8-8Q8hLoBVQaC77yox9XMO3ilHgFYWKCvaIbEC2qgQp-WOyoZSyUjVAz8izGPsUAgj-lJwxLoViLduQsJ2tGQr8aX3081QYt2AoJpxN16_3ZloKe4fjHEznzZKB5Q6D2R8Kn9guARa7IqBdkojNUXhTmGL6zabUuA6LtzhlUZMSh-jjc_LEmSHii9N5Tr6-f_fl5mO5_fTh9uZ6W1oh5FKia5XktZPKSo5UYeukEI1p7A5qhbWzlHPLJOw6NHInKDglWtYIcJ2lzPBzcnHU3Yf5x4px0aOPFofBpPbWqEEIzhWrW5HQ1w_Qfl5D-m-meMvrpq5louojZcMcY0Cn98GPJhw0UJ1N0b0-maKzKZqCTqakulcn9XU3Yve36o8LCbg6ApjGce8x6Gg95tH6PFrdzf6_T7x9oGAHP_lk7Xc8YPzXjY5MU_05b0ZeDOD5IiT_BTp-tns</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Yu, Chang Sik, M.D</creator><creator>Yun, Hae Ran, M.D</creator><creator>Shin, Eung Jin, M.D</creator><creator>Lee, Kang Yong, M.D</creator><creator>Kim, Nam Kyu, M.D</creator><creator>Lim, Seok-Byung, M.D</creator><creator>Oh, Seong Taek, M.D</creator><creator>Kang, Sung-Bum, M.D</creator><creator>Choi, Won Joon, M.D</creator><creator>Lee, Woo Yong, M.D</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis</title><author>Yu, Chang Sik, M.D ; Yun, Hae Ran, M.D ; Shin, Eung Jin, M.D ; Lee, Kang Yong, M.D ; Kim, Nam Kyu, M.D ; Lim, Seok-Byung, M.D ; Oh, Seong Taek, M.D ; Kang, Sung-Bum, M.D ; Choi, Won Joon, M.D ; Lee, Woo Yong, M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-ef79835f89c83e09e7f8446a6cb159e5fc033c281bdea8b401f9472641fdc02a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Chemoradiotherapy</topic><topic>Chemotherapy</topic><topic>Colorectal cancer</topic><topic>Female</topic><topic>Humans</topic><topic>Local excision</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Neoadjuvant chemoradiation therapy</topic><topic>Neoadjuvant Therapy</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Rectal cancer</topic><topic>Rectal Neoplasms - mortality</topic><topic>Rectal Neoplasms - pathology</topic><topic>Rectal Neoplasms - therapy</topic><topic>Rectum - surgery</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Chang Sik, M.D</creatorcontrib><creatorcontrib>Yun, Hae Ran, M.D</creatorcontrib><creatorcontrib>Shin, Eung Jin, M.D</creatorcontrib><creatorcontrib>Lee, Kang Yong, M.D</creatorcontrib><creatorcontrib>Kim, Nam Kyu, M.D</creatorcontrib><creatorcontrib>Lim, Seok-Byung, M.D</creatorcontrib><creatorcontrib>Oh, Seong Taek, M.D</creatorcontrib><creatorcontrib>Kang, Sung-Bum, M.D</creatorcontrib><creatorcontrib>Choi, Won Joon, M.D</creatorcontrib><creatorcontrib>Lee, Woo Yong, M.D</creatorcontrib><creatorcontrib>Colorectal Cancer Study Group, Korean Society of Coloproctology</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Chang Sik, M.D</au><au>Yun, Hae Ran, M.D</au><au>Shin, Eung Jin, M.D</au><au>Lee, Kang Yong, M.D</au><au>Kim, Nam Kyu, M.D</au><au>Lim, Seok-Byung, M.D</au><au>Oh, Seong Taek, M.D</au><au>Kang, Sung-Bum, M.D</au><au>Choi, Won Joon, M.D</au><au>Lee, Woo Yong, M.D</au><aucorp>Colorectal Cancer Study Group, Korean Society of Coloproctology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>206</volume><issue>4</issue><spage>482</spage><epage>487</epage><pages>482-487</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><abstract>Abstract Background The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. Methods From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis. Results Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor ( P = .040). Conclusions Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancer patients appears to be a safe and effective treatment, especially in pCR patients.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23849272</pmid><doi>10.1016/j.amjsurg.2013.01.042</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9610
ispartof The American journal of surgery, 2013-10, Vol.206 (4), p.482-487
issn 0002-9610
1879-1883
language eng
recordid cdi_proquest_miscellaneous_1443392574
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Aged
Aged, 80 and over
Chemoradiotherapy
Chemotherapy
Colorectal cancer
Female
Humans
Local excision
Male
Medical imaging
Middle Aged
Mortality
Neoadjuvant chemoradiation therapy
Neoadjuvant Therapy
Neoplasm Metastasis
Neoplasm Recurrence, Local
NMR
Nuclear magnetic resonance
Rectal cancer
Rectal Neoplasms - mortality
Rectal Neoplasms - pathology
Rectal Neoplasms - therapy
Rectum - surgery
Retrospective Studies
Surgery
title Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A24%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Local%20excision%20after%20neoadjuvant%20chemoradiation%20therapy%20in%20advanced%20rectal%20cancer:%20a%20national%20multicenter%20analysis&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Yu,%20Chang%20Sik,%20M.D&rft.aucorp=Colorectal%20Cancer%20Study%20Group,%20Korean%20Society%20of%20Coloproctology&rft.date=2013-10-01&rft.volume=206&rft.issue=4&rft.spage=482&rft.epage=487&rft.pages=482-487&rft.issn=0002-9610&rft.eissn=1879-1883&rft_id=info:doi/10.1016/j.amjsurg.2013.01.042&rft_dat=%3Cproquest_cross%3E1443392574%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1437356558&rft_id=info:pmid/23849272&rft_els_id=1_s2_0_S0002961013002948&rfr_iscdi=true